Your browser doesn't support javascript.
loading
Therapeutic Rationale to Target Highly Expressed CDK7 Conferring Poor Outcomes in Triple-Negative Breast Cancer.
Li, Bo; Ni Chonghaile, Triona; Fan, Yue; Madden, Stephen F; Klinger, Rut; O'Connor, Aisling E; Walsh, Louise; O'Hurley, Gillian; Mallya Udupi, Girish; Joseph, Jesuchristopher; Tarrant, Finbarr; Conroy, Emer; Gaber, Alexander; Chin, Suet-Feung; Bardwell, Helen A; Provenzano, Elena; Crown, John; Dubois, Thierry; Linn, Sabine; Jirstrom, Karin; Caldas, Carlos; O'Connor, Darran P; Gallagher, William M.
  • Li B; UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland.
  • Ni Chonghaile T; Department of Physiology & Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Fan Y; UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland.
  • Madden SF; Population Health Sciences Division, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Klinger R; UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland.
  • O'Connor AE; UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland.
  • Walsh L; Department of Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • O'Hurley G; OncoMark Ltd, Belfield Innovation Park, Dublin, Ireland.
  • Mallya Udupi G; OncoMark Ltd, Belfield Innovation Park, Dublin, Ireland.
  • Joseph J; OncoMark Ltd, Belfield Innovation Park, Dublin, Ireland.
  • Tarrant F; UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland.
  • Conroy E; UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland.
  • Gaber A; Lund University, Lund, Sweden.
  • Chin SF; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom.
  • Bardwell HA; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom.
  • Provenzano E; Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Crown J; Department of Medical Oncology, St. Vincent's University Hospital, Dublin, Ireland.
  • Dubois T; Institut Curie, PSL Research University, Department of Translational Research, Breast Cancer Biology Group, Paris, France.
  • Linn S; The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Jirstrom K; Lund University, Lund, Sweden.
  • Caldas C; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom.
  • O'Connor DP; Department of Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Gallagher WM; UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland. william.gallagher@ucd.ie.
Cancer Res ; 77(14): 3834-3845, 2017 07 15.
Article en En | MEDLINE | ID: mdl-28455421
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Quinasas Ciclina-Dependientes / Inhibidores de Proteínas Quinasas / Neoplasias de la Mama Triple Negativas Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Quinasas Ciclina-Dependientes / Inhibidores de Proteínas Quinasas / Neoplasias de la Mama Triple Negativas Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Año: 2017 Tipo del documento: Article